These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10565496)

  • 21. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease.
    Tiraboschi P; Hansen LA; Alford M; Merdes A; Masliah E; Thal LJ; Corey-Bloom J
    Arch Gen Psychiatry; 2002 Oct; 59(10):946-51. PubMed ID: 12365882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes of immunoreactive neuropeptide Y, somatostatin and corticotropin-releasing factor (CRF) in the brain of a novel epileptic mutant rat, Ihara's genetically epileptic rat (IGER).
    Takahashi Y; Sadamatsu M; Kanai H; Masui A; Amano S; Ihara N; Kato N
    Brain Res; 1997 Nov; 776(1-2):255-60. PubMed ID: 9439821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colocalization of peptide and glucocorticoid receptor immunoreactivities in rat central amygdaloid nucleus.
    Honkaniemi J; Pelto-Huikko M; Rechardt L; Isola J; Lammi A; Fuxe K; Gustafsson JA; Wikström AC; Hökfelt T
    Neuroendocrinology; 1992 Apr; 55(4):451-9. PubMed ID: 1373477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sleep disturbances are key symptoms of very early stage Alzheimer disease with behavioral and psychological symptoms: a Japan multi-center cross-sectional study (J-BIRD).
    Kabeshita Y; Adachi H; Matsushita M; Kanemoto H; Sato S; Suzuki Y; Yoshiyama K; Shimomura T; Yoshida T; Shimizu H; Matsumoto T; Mori T; Kashibayashi T; Tanaka H; Hatada Y; Hashimoto M; Nishio Y; Komori K; Tanaka T; Yokoyama K; Tanimukai S; Ikeda M; Takeda M; Mori E; Kudo T; Kazui H
    Int J Geriatr Psychiatry; 2017 Feb; 32(2):222-230. PubMed ID: 27001907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.
    Soininen HS; Jolkkonen JT; Reinikainen KJ; Halonen TO; Riekkinen PJ
    J Neurol Sci; 1984 Feb; 63(2):167-72. PubMed ID: 6142929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neuromodulators and Alzheimer's disease].
    Vallet PG; Bouras C
    Encephale; 1988; 14(5):345-51. PubMed ID: 2463900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration.
    Edvinsson L; Minthon L; Ekman R; Gustafson L
    Dementia; 1993; 4(3-4):167-71. PubMed ID: 8401787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
    Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
    J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of pituitary adenylate cyclase-activating polypeptide with cognitive decline in mild cognitive impairment due to Alzheimer disease.
    Han P; Caselli RJ; Baxter L; Serrano G; Yin J; Beach TG; Reiman EM; Shi J
    JAMA Neurol; 2015 Mar; 72(3):333-9. PubMed ID: 25599520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.
    Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ; Soininen H; Riekkinen PJ
    J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Caspase gene expression in the brain as a function of the clinical progression of Alzheimer disease.
    Pompl PN; Yemul S; Xiang Z; Ho L; Haroutunian V; Purohit D; Mohs R; Pasinetti GM
    Arch Neurol; 2003 Mar; 60(3):369-76. PubMed ID: 12633148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.
    Reinikainen KJ; Riekkinen PJ; Jolkkonen J; Kosma VM; Soininen H
    Brain Res; 1987 Jan; 402(1):103-8. PubMed ID: 3828777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution and chemical coding of corticotropin-releasing factor-immunoreactive neurons in the guinea pig enteric nervous system.
    Liu S; Gao N; Hu HZ; Wang X; Wang GD; Fang X; Gao X; Xia Y; Wood JD
    J Comp Neurol; 2006 Jan; 494(1):63-74. PubMed ID: 16304680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease.
    Davies CA; Morroll DR; Prinja D; Mann DM; Gibbs A
    J Neurol Sci; 1990 Apr; 96(1):59-73. PubMed ID: 1972185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in the neurochemical pathology of Alzheimer's disease. Studies of neuropeptides, cholinergic function and Alzheimer's disease-associated protein.
    Nemeroff CB; Bissette G; Slotkin TA; Seidler FJ; Miller BE; Ghanbari H
    Ann N Y Acad Sci; 1991; 640():193-6. PubMed ID: 1685644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes.
    Beal MF; Clevens RA; Mazurek MF
    Synapse; 1988; 2(4):463-7. PubMed ID: 2903567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Existence of mutual synaptic relations between corticotropin-releasing factor-containing and somatostatin-containing neurons in the rat hypothalamus.
    Hisano S; Daikoku S
    Brain Res; 1991 Apr; 545(1-2):265-75. PubMed ID: 1713527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.